# Prophylactic administration of metformin alleviates withdrawal symptoms associated with heroin

**Authors:** Minghong Liu, Junyu Jiang, Xiaolong Wu, Jiaxin Liu, Yang Liu, Shanshan Ling, Huichun Chen, Gongliang Zhang, Yuanhai Li, Gang Pang, Xinrong Tao

PMC · DOI: 10.3389/fphar.2025.1647624 · Frontiers in Pharmacology · 2025-10-08

## TL;DR

This study shows that metformin can reduce heroin withdrawal symptoms in mice by decreasing brain inflammation and cell death.

## Contribution

The study reveals a new potential use of metformin in alleviating heroin withdrawal through its anti-inflammatory effects in the hippocampus.

## Key findings

- Metformin improved movement and posture changes in heroin withdrawal mice.
- It reduced anxiety and neuroinflammation in the hippocampal CA3 region.
- Metformin downregulated TLR4 and BAX proteins linked to inflammation and apoptosis.

## Abstract

This study aimed to evaluate whether metformin can alleviate heroin withdrawal symptoms and explore its underlying mechanisms, focusing on its reducing microglia-related neuroinflammation in the CA3 region of hippocampus.

We set up a heroin withdrawal mouse model by the administration of naloxone in heroin-treated mice. To reduce experimental variables, only male mice were considered in this study. The behaviors of withdrawal model mice with saline, naloxone (5 mg/kg), or metformin (100 mg/kg) treatment (n = 12 for each group) were evaluated by Open Field Test (OFT) and Elevated Plus Maze Test. After the behavior tests, brain tissues were collected for histological staining experiments. Our study mainly focused on the hippocampal CA3 region. Protein expression levels of TLR4 (inflammation related) and BAX were analyzed using immunofluorescence staining.

Metformin was proved to be capable of improving movement-related and posture-related behavioral changes caused by the naloxone-induced heroin withdrawal. Furthermore, the results of the Open-Field Test and Elevated Plus Maze test were used to demonstrate metformin’s role in softening anxiety levels, which was due to its reducing microglia-related neuroinflammation in the CA3 region of hippocampus. This neuronal protection was achieved by downregulating the expression of TLR4 (inflammation related) and BAX (apoptosis marker) protein.

Overall, our data suggests that prophylactic administration of metformin has a therapeutic effect on glial-induced neuroinflammation and neuronal apoptosis in heroin withdrawal mice. Histological experiments suggested that metformin reduced microglia-mediated neuroinflammation and downregulated TLR4 and BAX expressions in the hippocampus.

## Linked entities

- **Proteins:** TLR4 (toll like receptor 4), BAX (BCL2 associated X, apoptosis regulator)
- **Chemicals:** metformin (PubChem CID 4091), heroin (PubChem CID 5462328), naloxone (PubChem CID 4425)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Bax (BCL2-associated X protein) [NCBI Gene 12028]
- **Diseases:** anxiety (MESH:D001007), neuroinflammation (MESH:D000090862), inflammation (MESH:D007249)
- **Chemicals:** Metformin (MESH:D008687), heroin (MESH:D003932), naloxone (MESH:D009270)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12541182/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12541182/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12541182/full.md

---
Source: https://tomesphere.com/paper/PMC12541182